Monday, April 01, 2024 11:06:03 AM
Recent IMNN News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 12:15:54 PM
- IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO • GlobeNewswire Inc. • 05/08/2024 12:00:00 PM
- IMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024 • GlobeNewswire Inc. • 05/06/2024 03:00:00 PM
- IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101 • GlobeNewswire Inc. • 04/18/2024 12:30:00 PM
- IMUNON Reports Compliance with Nasdaq Listing Requirements • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- IMUNON Reports 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/28/2024 12:00:00 PM
- IMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating Losses • GlobeNewswire Inc. • 03/25/2024 12:30:00 PM
- IMUNON to Hold 2023 Financial Results and Business Update Conference Call on Thursday, March 28, 2024 • GlobeNewswire Inc. • 03/21/2024 09:00:00 PM
- IMUNON Files IND Application to Begin Human Testing of IMNN-101 • GlobeNewswire Inc. • 03/13/2024 12:00:00 PM
- IMUNON Announces Leadership Change • GlobeNewswire Inc. • 03/12/2024 09:00:00 PM
- Independent Lab Confirms Immunogenicity and Protection with IMUNON’s IMNN-101 in a Live Virus Challenge Against SARS-CoV-2 Variant XBB.1.5 • GlobeNewswire Inc. • 02/29/2024 01:30:00 PM
- Memorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON’s IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancer • GlobeNewswire Inc. • 02/27/2024 01:30:00 PM
- IMNN-101 Preclinical Data in SARS CoV-2 Published in Peer-Reviewed Journal Vaccine • GlobeNewswire Inc. • 02/22/2024 01:00:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 09:09:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 09:30:19 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/20/2023 10:15:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2023 09:07:24 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2023 09:05:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:35:13 PM
- IMUNON Appoints Dr. Sebastien Hazard as Chief Medical Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/11/2023 01:30:00 PM
- IMUNON’s VP of R&D to Present at the Vaccines Summit-2023 • GlobeNewswire Inc. • 11/14/2023 02:00:00 PM
- IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 11/14/2023 01:00:00 PM
- IMUNON to Hold Third Quarter 2023 Financial Results and Business Update Conference Call on Tuesday, November 14, 2023 • GlobeNewswire Inc. • 11/07/2023 01:30:00 PM
- IMUNON’s Chief Science Officer to Present at the 3rd International Vaccines Congress • GlobeNewswire Inc. • 10/23/2023 12:30:00 PM
- IMUNON CEO Dr. Corinne Le Goff to Participate in a Panel Discussion on Pandemic Preparedness at the United Nations • GlobeNewswire Inc. • 10/19/2023 12:30:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM